My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Vascular endothelial growth factor biology: clinical implications for ocular treatments.

    Bhisitkul RB.

    Br J Ophthalmol. 2006 Dec;90(12):1542-7. Review.PMID: 17114590 [PubMed - indexed for MEDLINE]Related articles

    2.

    Anti-vascular endothelial growth factor therapy for ocular neovascular disease.

    Andreoli CM, Miller JW.

    Curr Opin Ophthalmol. 2007 Nov;18(6):502-8. Review.PMID: 18163003 [PubMed - indexed for MEDLINE]Related articles

    3.

    Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.

    Ciulla TA, Rosenfeld PJ.

    Curr Opin Ophthalmol. 2009 May;20(3):166-74. Review.PMID: 19381089 [PubMed - indexed for MEDLINE]Related articles

    4.

    [VEGF, anti-vEGF and diseases]

    Corvol P.

    Bull Acad Natl Med. 2008 Feb;192(2):289-300; discussion 300-2. Review. French. PMID: 18819684 [PubMed - indexed for MEDLINE]Related articles

    5.

    Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.

    Eyetech Study Group.

    Retina. 2002 Apr;22(2):143-52.PMID: 11927845 [PubMed - indexed for MEDLINE]Related articles

    6.

    VEGF function in vascular pathogenesis.

    Ng YS, Krilleke D, Shima DT.

    Exp Cell Res. 2006 Mar 10;312(5):527-37. Epub 2005 Dec 5. Review.PMID: 16330026 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.

    Ciulla TA, Rosenfeld PJ.

    Curr Opin Ophthalmol. 2009 May;20(3):158-65. Review.PMID: 19417570 [PubMed - indexed for MEDLINE]Related articles

    8.

    Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.

    Ferrara N.

    Semin Oncol. 2002 Dec;29(6 Suppl 16):10-4. Review.PMID: 12516033 [PubMed - indexed for MEDLINE]Related articles

    9.

    Anti-VEGF therapy: riding the wave of change.

    Hunyor AP.

    Clin Experiment Ophthalmol. 2008 Jul;36(5):401-2. No abstract available. PMID: 18925912 [PubMed - indexed for MEDLINE]Related articles

    10.

    [VEGF in age-related macular degeneration. Part I. Physiologic and pathologic role of VEGF]

    Wylegała E, Teper SJ.

    Klin Oczna. 2007;109(1-3):94-6. Review. Polish. PMID: 17687924 [PubMed - indexed for MEDLINE]Related articles

    11.

    The function of vascular endothelial growth factor.

    Nieves BJ, D'Amore PA, Bryan BA.

    Biofactors. 2009 Jul-Aug;35(4):332-7. Review.PMID: 19415738 [PubMed - indexed for MEDLINE]Related articles

    12.

    Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

    Ferrara N, Damico L, Shams N, Lowman H, Kim R.

    Retina. 2006 Oct;26(8):859-70. Review.PMID: 17031284 [PubMed - indexed for MEDLINE]Related articles

    13.

    Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies.

    Csaky K, Do DV.

    Am J Ophthalmol. 2009 Nov;148(5):647-56. Epub 2009 Aug 26.PMID: 19712924 [PubMed - indexed for MEDLINE]Related articles

    14.

    Introduction: Understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration.

    Bressler SB.

    Ophthalmology. 2009 Oct;116(10 Suppl):S1-7. Review.PMID: 19800534 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series]

    Meyer CH, Helb HM, Eter N.

    Ophthalmologe. 2008 Feb;105(2):125-38, 140-2. Review. German. PMID: 18256841 [PubMed - indexed for MEDLINE]Related articles

    16.

    Promising new treatments for neovascular age-related macular degeneration.

    Michels S, Schmidt-Erfurth U, Rosenfeld PJ.

    Expert Opin Investig Drugs. 2006 Jul;15(7):779-93. Review.PMID: 16787141 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pegaptanib sodium for the treatment of age-related macular degeneration.

    Apte RS.

    Expert Opin Pharmacother. 2008 Feb;9(3):499-508. Review.PMID: 18220500 [PubMed - indexed for MEDLINE]Related articles

    18.

    Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.

    Eyetech Study Group.

    Ophthalmology. 2003 May;110(5):979-86.PMID: 12750101 [PubMed - indexed for MEDLINE]Related articles

    19.

    Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.

    Shibuya M.

    BMB Rep. 2008 Apr 30;41(4):278-86. Review.PMID: 18452647 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The new face of age-related macular degeneration.

    Giuliari GP, Ciardella AP.

    Can J Ophthalmol. 2007 Aug;42(4):629-30. No abstract available. PMID: 17641716 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity